Literature DB >> 3101525

Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa.

R Swanepoel, A J Shepherd, P A Leman, S P Shepherd, G M McGillivray, M J Erasmus, L A Searle, D E Gill.   

Abstract

Following the diagnosis in 1981 of the first case of Crimean-Congo hemorrhagic fever (CCHF) in South Africa, an antibody survey was undertaken on cattle sera to determine the distribution of the virus and specific diagnostic tests were routinely applied to specimens from suspected cases of hemorrhagic fever to establish the medical significance of its presence. Antibody to CCHF virus was demonstrated by reversed passive hemagglutination-inhibition technique in 2,460/8,667 (28%) cattle sera and in 140/180 herds tested in South Africa, as well as in 347/763 (45%) cattle sera and in 32/34 (94%) herds tested in Zimbabwe. The antibody was found in all major cattle farming areas, but was of low prevalence along the southern coast where 2 of the 3 species of Hyalomma tick which occur in South Africa are absent. From February 1981 to January 1986, inclusive, 29 indigenous cases of CCHF were diagnosed in 16 outbreaks which arose in various locations throughout South Africa. A further 2 imported cases of CCHF arose in Zaire and Tanzania. The clinical features of infection conformed to the classical descriptions of CCHF in the Soviet Union. The fatal outcome in 11/31 cases indicates that the African disease is no less severe than that which occurs in Eurasia. It is inferred that the virus is widespread in all countries in Africa and Eurasia which lie within the limits of world distribution of ticks of the genus Hyalomma.

Entities:  

Mesh:

Year:  1987        PMID: 3101525     DOI: 10.4269/ajtmh.1987.36.120

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  60 in total

1.  Crimean-Congo hemorrhagic fever virus activates endothelial cells.

Authors:  Anne-Marie Connolly-Andersen; Guido Moll; Cecilia Andersson; Sara Akerström; Helen Karlberg; Iyadh Douagi; Ali Mirazimi
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus.

Authors:  Angela J Sanchez; Martin J Vincent; Stuart T Nichol
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Authors:  Varough M Deyde; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein.

Authors:  Stephen D Carter; Rebecca Surtees; Cheryl T Walter; Antonio Ariza; Éric Bergeron; Stuart T Nichol; Julian A Hiscox; Thomas A Edwards; John N Barr
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

5.  Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever.

Authors:  Enver Sancakdar; Ahmet Sami Güven; Elif Bilge Uysal; Ali Kaya; Köksal Deveci; Hekim Karapınar; Ismail Akkar
Journal:  Int J Clin Exp Med       Date:  2014-03-15

6.  Serological evaluation of Crimean-Congo hemorrhagic fever in humans with high-risk professions living in enzootic regions of Isfahan province of Iran and genetic analysis of circulating strains.

Authors:  Sadegh Chinikar; Seyed M Ghiasi; Saeed Naddaf; Norair Piazak; Maryam Moradi; Mohammad R Razavi; Neda Afzali; Ali Haeri; Kamyar Mostafavizadeh; Behrouz Ataei; Mohammad Khalilifard-Brojeni; Sayed M Husseini; Michele Bouloy
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

7.  Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein Augments mRNA Translation.

Authors:  Subbiah Jeeva; Erdong Cheng; Safder S Ganaie; Mohammad A Mir
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

8.  [Vulvovaginal candidiasis in childhood--diagnostic and therapeutic results].

Authors:  P Vasileva; K Bozhkova
Journal:  Akush Ginekol (Sofiia)       Date:  2001

9.  Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.

Authors:  Helen Karlberg; Gunnel Lindegren; Ali Mirazimi
Journal:  Open Virol J       Date:  2010-04-22

Review 10.  Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis.

Authors:  Karla Soares-Weiser; Sherine Thomas; Gail Thomson; Paul Garner
Journal:  BMC Infect Dis       Date:  2010-07-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.